Is Fulgent Genetics (flgt) stock a strong Buy Right Now?
AAWW, BERY, CAL, FLGT, and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on December 28th. Fulgent Genetics, Inc. (FLGT) stock has soared in 2021, rising +92.3%.
How much is a share of Fulgent worth?
One share of FLGT stock can currently be purchased for approximately $69.86. How much money does Fulgent Genetics make? Fulgent Genetics has a market capitalization of $2.08 billion and generates $421.71 million in revenue each year. The company earns $214.31 million in net income (profit) each year or $19.20 on an earnings per share basis.
How did Fulgent Genetics'shares rise 93% last year?
Shares of diagnostic testing company Fulgent Genetics (NASDAQ: FLGT) were up 93% last year, according to S&P Global Market Intelligence. The unpredictability of COVID took shareholders on a journey through several peaks and valleys on the way to that gain.
What other companies does Fulgent Genetics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT).
Is Fulgent Genetics a buy?
In aggregate, Fulgent Genetics currently has a Zacks Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes Fulgent Genetics a solid choice for value investors.
How much cash does Fulgent Genetics have?
While it is always sensible to investigate a company's debt, in this case Fulgent Genetics has US$564.0m in net cash and a decent-looking balance sheet.
What sector is Fulgent Genetics in?
technology companyFulgent Genetics, Inc. is a technology company, which offers COVID-19 testing services, molecular diagnostic testing services and comprehensive genetic testing designed to provide physicians and patients with clinically actionable diagnostic information to improve the patient care quality.
Who owns fulgent genetics?
Ming HsiehMing Hsieh is the founder, president, CEO and chair of Fulgent Genetics, a genetic testing technology company. He started Fulgent Genetics in 2011 and took the company public in 2016.
What is the fulgent system?
Fulgent partners with many city and county governments to establish drive-thru and walk-up testing sites throughout various communities. Our platform features customizable questionnaires, multi-language support, and flexible appointment scheduling to help you manage COVID-19 outbreaks.
Should I buy or sell Fulgent Genetics stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1...
What is Fulgent Genetics' stock price forecast for 2022?
2 brokers have issued 1 year target prices for Fulgent Genetics' shares. Their forecasts range from $65.00 to $125.00. On average, they anticipate...
How has Fulgent Genetics' stock price performed in 2022?
Fulgent Genetics' stock was trading at $100.59 on January 1st, 2022. Since then, FLGT shares have decreased by 50.8% and is now trading at $49.54....
When is Fulgent Genetics' next earnings date?
Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for Fulge...
How were Fulgent Genetics' earnings last quarter?
Fulgent Genetics, Inc. (NASDAQ:FLGT) posted its quarterly earnings results on Tuesday, May, 3rd. The company reported $5.08 earnings per share (EPS...
What guidance has Fulgent Genetics issued on next quarter's earnings?
Fulgent Genetics updated its second quarter 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of f...
Who are Fulgent Genetics' key executives?
Fulgent Genetics' management team includes the following people: Mr. Ming Hsieh , Chairman, CEO & Pres (Age 66, Pay $5.66M) Mr. Paul Kim , Chie...
Who are some of Fulgent Genetics' key competitors?
Some companies that are related to Fulgent Genetics include Guardant Health (GH) , Natera (NTRA) , Elekta AB (publ) (EKTAY) , CareDx (CDNA) ,...
What other stocks do shareholders of Fulgent Genetics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA) , CR...
What is marketbeat ratings?
How much does Fulgent Genetics make?
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is the official website of Fulgent Genetics?
Fulgent Genetics has a market capitalization of $2.39 billion and generates $421.71 million in revenue each year. The company earns $214.31 million in net income (profit) each year or $8.85 on an earnings per share basis.
What is the ticker symbol for Fulgent Genetics?
The official website for Fulgent Genetics is www.fulgentgenetics.com.
What is the average rating of Fulgent Genetics?
Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."
What is Fulgent Genetics?
Fulgent Genetics has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, no hold ratings, and 1 sell rating.
When will Fulgent Genetics release its earnings for 2021?
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
How to calculate money flow?
Fulgent Genetics issued an update on its second quarter 2021 earnings guidance on Thursday, May, 27th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $200 million-$200 million, compared to the consensus revenue estimate of $193.95 million.
How long are futures trading delayed?
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.
How often do exchanges report short interest?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
How to calculate market cap?
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
What is dividend percentage?
Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
How to calculate restricted stock?
A company's dividend expressed as a percentage of its current stock price.
What is market capitalization for companies?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
How many articles has The Fool written?
For companies with multiple common share classes, market capitalization includes both classes. Shares Outstanding. Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. Public Float.
What company delivered a solid performance in Q3?
The Fool has written over 100 articles on Fulgent Genetics, Inc..
What test is used in New York City?
The genetic testing company delivered a solid performance in Q3.
What is governance score?
New York City will use the company's COVID-19 test in its public school system.
What is the environmental score?
The governance score is comprised of weighted key performance indicators related to leadership, management, and business model.
When will FLGT earnings end?
The environmental score is comprised of weighted key performance indicators related to natural capital, innovation, and climate change.
Is Medallia cashing out?
FLGT earnings call for the period ending June 30, 2021.
Transparency is our policy. Learn how it impacts everything we do
With this particular acquisition, Medallia shareholders are being cashed out. Here are two ideas for that cash.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
What is Fulgent Genetics?
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
What is market cap?
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequ
Does market cap include convertible securities?
Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements.
Is Fulgent Genetics Inc stock A Buy?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
How much is Fulgent Genetics stock worth in 2021?
Fulgent Genetics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Is Fulgent Genetics a sell or buy stock?
The Fulgent Genetics Inc stock price gained 2.13% on the last trading day (Friday, 9th Jul 2021), rising from $85.94 to $87.77. During the day the stock fluctuated 3.99% from a day low at $84.53 to a day high of $87.90. The price has fallen in 6 of the last 10 days, but is still up by 5.08% over the past 2 weeks. Volume fell on the last day by -282 thousand shares and in total, 318 thousand shares were bought and sold for approximately $27.87 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
What is style score?
The Fulgent Genetics Inc stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $92.53. On a fall, the stock will find some support from the long-term average at approximately $85.21. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 17, 2021, and so far it has fallen -9.07%. Further fall is indicated until a new bottom pivot has been found.
What is ZER research?
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
How many sectors are there in Zacks?
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
What are the different grades for stocks?
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.
Is a B better than a C?
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
